2. Bassett J. International Diabetes Institute. World Health Organization, Regional Office for the Western Pacific. International Association for the Study of Obesity. International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. 2000. Australia: Health Communications Australia.
3. Korea Centers for Disease Control and Prevention. The Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV), 2008. 2009. Seoul: Ministry for Health, Welfare and Family Affairs; (Korean).
4. Wong MS, Gu K, Heng D, Chew SK, Chew LS, Tai ES. The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward? Diabetes Care 2003; 26: 3024-3030. 14578234. PMID:
14578234
6. Valensi P, Schwarz EH, Hall M, Felton AM, Maldonato A, Mathieu C. Pre-diabetes essential action: a European perspective. Diabetes Metab 2005; 31: 606-620. 16357812. PMID:
16357812
7. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R. Baltimore Longitudinal Study of Aging. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 2003; 52: 1475-1484. 12765960. PMID:
12765960
8. Lecomte P, Vol S, Cacès E, Born C, Chabrolle C, Lasfargues G, et al. Five-year predictive factors of type 2 diabetes in men with impaired fasting glucose. Diabetes Metab 2007; 33: 140-147. 17320447. PMID:
17320447
10. Baena-Díez JM, Elosua R, Cano JF, Masiá R, Sala J, Marrugat J, et al. Waist circumference and impaired fasting glucose screening in a Mediterranean population. Diabetes Res Clin Pract 2009; 86: e12-e14. 19744741. PMID:
19744741
11. Chang SA, Kim HS, Yoon KH, Ko SH, Kwon HS, Kim SR, et al. Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea. Metabolism 2004; 53: 142-146. 14767863. PMID:
14767863
12. Park IB, Baik SH. Epidemiologic characteristics of diabetes mellitus in Korea: current status of diabetic patients using Korean Health Insurance Database. Korean Diabetes J 2009; 33: 357-362 (Korean).
13. Yoon SJ, Lee HS, Lee SW, Yun JE, Kim SY, Cho ER, et al. The association between adiponectin and diabetes in the Korean population. Metabolism 2008; 57: 853-857. 18502270. PMID:
18502270
14. Yun JE, Sull JW, Lee HY, Park E, Kim S, Jo J, et al. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients. Diabetes Metab Res Rev 2009; 25: 259-265. 19214966. PMID:
19214966
15. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83. 10092513. PMID:
10092513
16. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935. 11344187. PMID:
11344187
17. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 2002; 103: 137-142. 12149104. PMID:
12149104
18. Jee SH, Lee S, Min S, Park J, Kim HS, Kim SY, et al. Development of ELISA-kit of quantitative analysis for adiponectin and their correlation with cardiovascular risk factors. Korean J Epidemiol 2007; 29: 165-175 (Korean).
19. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998; 47: 699-713. 9588440. PMID:
9588440
20. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001; 50: 1126-1133. 11334417. PMID:
11334417
21. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946. 11479627. PMID:
11479627
22. Nilsson PM, Engström G, Hedblad B, Frystyk J, Persson MM, Berglund G, et al. Plasma adiponectin levels in relation to carotid intima media thickness and markers of insulin resistance. Arterioscler Thromb Vasc Biol 2006; 26: 2758-2762. 17038635. PMID:
17038635
23. Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, et al. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2004; 53: 2473-2478. 15331562. PMID:
15331562
24. Greenfield JR, Campbell LV. Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Curr Diabetes Rev 2006; 2: 195-211. 18220627. PMID:
18220627
25. Shand BI, Scott RS, Lewis JG, Elder PA, Frampton CM. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study. Int J Obes (Lond) 2009; 33: 1274-1279. 19721448. PMID:
19721448
26. Knobler H, Benderly M, Boyko V, Behar S, Matas Z, Rubinstein A, et al. Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucose. Eur J Endocrinol 2006; 154: 87-92. 16381996. PMID:
16381996
27. Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, et al. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol (Oxf) 2004; 61: 75-80. 15212647. PMID:
15212647
28. Wang Z, Zhuo Q, Fu P, Piao J, Tian Y, Xu J, et al. Are the associations of plasma leptin and adiponectin with type 2 diabetes independent of obesity in older Chinese adults? Diabetes Metab Res Rev 2010; 26: 109-114. 20058257. PMID:
20058257
29. Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G, et al. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study. Diabetes Care 2006; 29: 2498-2503. 17065691. PMID:
17065691